Aspen Pharmacare Holdings Stock Net Income
| APNHY Stock | USD 7.75 0.51 7.04% |
As of the 14th of February 2026, Aspen Pharmacare shows the Mean Deviation of 1.95, downside deviation of 2.45, and Risk Adjusted Performance of 0.1246. Aspen Pharmacare Holdings technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aspen Pharmacare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Aspen Pharmacare's valuation are provided below:Aspen Pharmacare Holdings does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Aspen |
Aspen Pharmacare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aspen Pharmacare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aspen Pharmacare.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Aspen Pharmacare on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Aspen Pharmacare Holdings or generate 0.0% return on investment in Aspen Pharmacare over 90 days. Aspen Pharmacare is related to or competes with HUTCHMED (China), Sihuan Pharmaceutical, Curaleaf Holdings, Dermapharm Holding, Hypera SA, Haw ParLtd, and CanSino Biologics. Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharm... More
Aspen Pharmacare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aspen Pharmacare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aspen Pharmacare Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.45 | |||
| Information Ratio | 0.1263 | |||
| Maximum Drawdown | 30.3 | |||
| Value At Risk | (3.25) | |||
| Potential Upside | 5.99 |
Aspen Pharmacare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspen Pharmacare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aspen Pharmacare's standard deviation. In reality, there are many statistical measures that can use Aspen Pharmacare historical prices to predict the future Aspen Pharmacare's volatility.| Risk Adjusted Performance | 0.1246 | |||
| Jensen Alpha | 0.5621 | |||
| Total Risk Alpha | 0.2574 | |||
| Sortino Ratio | 0.1956 | |||
| Treynor Ratio | (1.43) |
Aspen Pharmacare February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1246 | |||
| Market Risk Adjusted Performance | (1.42) | |||
| Mean Deviation | 1.95 | |||
| Semi Deviation | 1.2 | |||
| Downside Deviation | 2.45 | |||
| Coefficient Of Variation | 691.14 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.43 | |||
| Information Ratio | 0.1263 | |||
| Jensen Alpha | 0.5621 | |||
| Total Risk Alpha | 0.2574 | |||
| Sortino Ratio | 0.1956 | |||
| Treynor Ratio | (1.43) | |||
| Maximum Drawdown | 30.3 | |||
| Value At Risk | (3.25) | |||
| Potential Upside | 5.99 | |||
| Downside Variance | 6.01 | |||
| Semi Variance | 1.45 | |||
| Expected Short fall | (4.84) | |||
| Skewness | 4.41 | |||
| Kurtosis | 27.09 |
Aspen Pharmacare Holdings Backtested Returns
Aspen Pharmacare appears to be slightly risky, given 3 months investment horizon. Aspen Pharmacare Holdings secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17 % return per unit of risk over the last 3 months. By analyzing Aspen Pharmacare's technical indicators, you can evaluate if the expected return of 0.67% is justified by implied risk. Please makes use of Aspen Pharmacare's Downside Deviation of 2.45, risk adjusted performance of 0.1246, and Mean Deviation of 1.95 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Aspen Pharmacare holds a performance score of 13. The firm shows a Beta (market volatility) of -0.38, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Aspen Pharmacare are expected to decrease at a much lower rate. During the bear market, Aspen Pharmacare is likely to outperform the market. Please check Aspen Pharmacare's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Aspen Pharmacare's price patterns will revert.
Auto-correlation | 0.20 |
Weak predictability
Aspen Pharmacare Holdings has weak predictability. Overlapping area represents the amount of predictability between Aspen Pharmacare time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aspen Pharmacare Holdings price movement. The serial correlation of 0.2 indicates that over 20.0% of current Aspen Pharmacare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Aspen Pharmacare Holdings reported net income of 8.67 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is significantly lower than that of the firm.
Aspen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aspen Pharmacare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Aspen Pharmacare could also be used in its relative valuation, which is a method of valuing Aspen Pharmacare by comparing valuation metrics of similar companies.Aspen Pharmacare is currently under evaluation in net income category among its peers.
Aspen Fundamentals
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 4.58 B | |||
| Shares Outstanding | 444.95 M | |||
| Price To Earning | 12.24 X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 0.09 X | |||
| Revenue | 38.61 B | |||
| Gross Profit | 18.29 B | |||
| EBITDA | 10.61 B | |||
| Net Income | 8.67 B | |||
| Cash And Equivalents | 6.18 B | |||
| Cash Per Share | 13.90 X | |||
| Total Debt | 105 M | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 1.48 X | |||
| Book Value Per Share | 159.44 X | |||
| Cash Flow From Operations | 5.37 B | |||
| Earnings Per Share | 0.77 X | |||
| Number Of Employees | 8.58 K | |||
| Beta | 0.62 | |||
| Market Capitalization | 3.69 B | |||
| Total Asset | 111.38 B | |||
| Retained Earnings | 28.4 B | |||
| Working Capital | 16.1 B | |||
| Current Asset | 37.2 B | |||
| Current Liabilities | 21.1 B | |||
| Z Score | 21.0 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 111.38 B | |||
| Last Dividend Paid | 3.26 |
About Aspen Pharmacare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aspen Pharmacare Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aspen Pharmacare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aspen Pharmacare Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aspen Pink Sheet Analysis
When running Aspen Pharmacare's price analysis, check to measure Aspen Pharmacare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspen Pharmacare is operating at the current time. Most of Aspen Pharmacare's value examination focuses on studying past and present price action to predict the probability of Aspen Pharmacare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspen Pharmacare's price. Additionally, you may evaluate how the addition of Aspen Pharmacare to your portfolios can decrease your overall portfolio volatility.